This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
5 ETFs That Are Investors' Favorite Amid Geopolitics
by Sweta Killa
While U.S. equities bled $2.2 billion in assets, U.S. fixed income and international equities pulled in $2.6 billion and $2.4 billion in capital, respectively. As such, ETFs overall saw inflows of about $2.6 billion.
ETF Asset Report for January: Stocks, Energy & Gold Win
by Sanghamitra Saha
Wall Street has been on choppy ride since the start of 2022 on rising rate worries. Still, investors poured money into stocks, both U.S. and developed market.
Who's Afraid of the Hawkish Fed? Stocks to Buy On Sale
by Kevin Cook
This market tantrum looks a lot like 2018 when credit markets choked and the Fed retracted its talons.
The Zacks Analyst Blog Highlights: SPY, VV, VTI, TQQQ and XLF
by Zacks Equity Research
SPY, VV, VTI, TQQQ and XLF are included in this analyst blog.
5 Most-Loved ETFs to Start 2022
by Sweta Killa
ETFs overall gathered about $24 billion capital last week, up $7.1 billion inflows recorded in the first week of 2021.
Nasdaq ETFs Worth Betting on Before Major Tech Earnings Releases
by Sweta Jaiswal, FRM
Here we highlight a few ETFs that can gain from the strength in the tech-heavy Nasdaq Composite.
The Zacks Analyst Blog Highlights: SOXL, TQQQ, CURE, FAS and RETL
by Zacks Equity Research
The Zacks Analyst Blog Highlights: SOXL, TQQQ, CURE, FAS and RETL
Best Leveraged ETF Areas of Past Decade
by Sanghamitra Saha
Fed's massive stimulus, record-bottom rates, fat fiscal stimulus in times of crisis, a divided Congress, a faster-than-expected rollout of coronavirus vaccines and chances of an antiviral treatment have been propelling the space.
5 Most-Loved ETFs of Last Week
by Sweta Killa
ETFs overall saw inflows of more than $4.3 billion for the week (Oct 1-7) with international equity ETFs leading the way higher.
Correction Not Over: Indicators to Watch for Capitulation
by Kevin Cook
Lots of bottom-callers are wishing it was over, but the pain has hardly begun.